Loading…
Claritev Corporation is projected to rise to $29.09 by 2027, a +28% move from its current price of $22.71. CTEV is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $21.71 | $22.74 | $23.82 | +0.14% |
| Aug 4 | $21.33 | $22.77 | $24.32 | +0.28% |
| Aug 5 | $21.05 | $22.81 | $24.71 | +0.43% |
| Aug 6 | $20.82 | $22.84 | $25.06 | +0.57% |
| Aug 7 | $20.62 | $22.87 | $25.37 | +0.71% |
| Aug 8 | $20.44 | $22.90 | $25.66 | +0.85% |
| Aug 9 | $20.29 | $22.94 | $25.93 | +0.99% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.29 | $22.94 | $25.93 | +0.99% |
| Week 2 | $19.47 | $23.16 | $27.56 | +2.00% |
| Week 3 | $18.91 | $23.39 | $28.94 | +3.01% |
| Week 4 | $18.48 | $23.63 | $30.20 | +4.04% |
| Week 5 | $18.13 | $23.86 | $31.40 | +5.07% |
| Week 6 | $17.84 | $24.10 | $32.55 | +6.12% |
| Week 7 | $17.59 | $24.34 | $33.68 | +7.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Claritev Corporation (CTEV) operates in the Healthcare sector, providing data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the United States healthcare industry. Its services span claims intelligence, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Claritev Corporation (CTEV) is a healthcare-focused data analytics and services company. It currently trades at $23.40 per share and has a market capitalization of $398.92M, with a market rank of 3213.
The near-term technical picture shows mixed momentum. The RSI14 is 40, and the price sits below the SMA50 of $27.87 and the SMA200 of $31.72.
The multi-year outlook is bullish, with forecasts showing continued upside into 2030 and beyond. The 2026 average price is $23.40, rising to $51.21 by 2030, $210.13 by 2040, and $540.05 by 2050, with implied ROIs of 0, 118.8, 798, and 2207.9 respectively. Bullish sentiment is noted for 2030, 2040, and 2050.
A major floor 41.7% below — a decisive break under it would weaken the trend.
The nearest floor, 4.8% below — buyers have tended to step in here.
The nearest ceiling, 52.9% above — a clean break opens room to run.
A major ceiling 73.7% above — clearing it would confirm fresh momentum.
Key CTEV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CTEV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.84 | Sell | $23.23 | Sell |
| MA 10 | $24.29 | Sell | $24.42 | Sell |
| MA 20 | $27.63 | Sell | $26.31 | Sell |
| MA 50 | $28.14 | Sell | $27.02 | Sell |
| MA 100 | $23.93 | Sell | $27.07 | Sell |
| MA 200 | $31.42 | Sell | $29.44 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.67 | Neutral |
| Stoch RSI (14) | 25.71 | Neutral |
| CCI (20) | -88.65 | Neutral |
| Williams %R (14) | -87.98 | Info |
| MACD (12,26,9) | -0.72 | Sell |
| ROC (12) | -22.86 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 12.02 | Buy |
| TRIX (15) | -0.58 | Sell |
| Awesome (5,34) | -6.39 | Sell |
| Ultimate (7,14,28) | 31.90 | Neutral |
| Momentum (10) | -7.68 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 22.84 | Sell |
| ADX (14) | 20.82 | Sell |
| ATR (14) | 1.12 | Info |
Near-term technical picture: NEUTRAL. The RSI14 is 40, indicating modest momentum.
The price is trading below the 50-day simple moving average at $27.87 and the 200-day simple moving average at $31.72, suggesting limited near-term upside momentum.
The 30-day trading range spans $16.98 to $32.25, with a nearby support at $21.61 and a resistance at $34.72. The stock exhibits elevated volatility, reflected in an annualized volatility of 90%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.47 | $22.71 | $37.50 | 0% | Neutral | |
| $21.73 | $29.09 | $41.92 | +28% | Bullish | |
| $23.66 | $33.37 | $50.97 | +47% | Bullish | |
| $28.52 | $42.02 | $67.11 | +85% | Bullish | |
| $32.58 | $49.92 | $82.70 | +120% | Bullish | |
| $45.67 | $72.57 | $124.10 | +220% | Bullish | |
| $52.92 | $87.04 | $153.10 | +283% | Bullish | |
| $55.86 | $94.95 | $171.28 | +318% | Bullish | |
| $60.53 | $106.20 | $196.04 | +368% | Bullish | |
| $57.53 | $104.11 | $196.29 | +358% | Bullish | |
| $97.73 | $204.78 | $421.38 | +802% | Bullish | |
| $234.48 | $521.06 | $1,198.44 | +21.9x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $13.47 | $22.71 | $30.06 | +0.00% |
| September 2026 | $21.37 | $25.80 | $32.39 | +13.60% |
| October 2026 | $21.14 | $25.84 | $33.01 | +0.14% |
| November 2026 | $21.78 | $26.87 | $34.82 | +4.00% |
| December 2026 | $22.95 | $28.57 | $37.50 | +6.34% |
Click any year to see its month-by-month CTEV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CTEV is projected to trade between $13.47 and $37.50, averaging $22.71 — a potential gain of 0% from today's $22.71. A consolidation phase looks the most probable path here.
Claritev Corporation's 2027 outlook centres on $29.09, within a $21.73 to $41.92 range. That is up +28% on the projected 2026 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2028, CTEV could reach as high as $50.97, with a base case around $33.37 and support toward $23.66 — roughly +47% from $22.71. Buyers look set to stay in control over this stretch.
Expect CTEV to range from $28.52 to $67.11 through 2029. The $42.02 average target implies a +85% move from current prices. That is up +26% on the projected 2028 average. Momentum favours further upside here.
The CTEV price prediction for 2030 points to an average of $49.92 (low $32.58, high $82.70) — a potential gain of +120% on today's $22.71. Buyers look set to stay in control over this stretch.
In 2031, CTEV is projected to trade between $45.67 and $124.10, averaging $72.57 — a potential gain of +220% from today's $22.71. That is up +45% on the projected 2030 average. Momentum favours further upside here.
Claritev Corporation's 2032 outlook centres on $87.04, within a $52.92 to $153.10 range. That is up +20% on the projected 2031 average. That marks a +283% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CTEV could reach as high as $171.28, with a base case around $94.95 and support toward $55.86 — roughly +318% from $22.71. Momentum favours further upside here.
Expect CTEV to range from $60.53 to $196.04 through 2034. The $106.20 average target implies a +368% move from current prices. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CTEV price prediction for 2035 points to an average of $104.11 (low $57.53, high $196.29) — a potential gain of +358% on today's $22.71. Momentum favours further upside here.
In 2040, CTEV is projected to trade between $97.73 and $421.38, averaging $204.78 — a potential gain of +802% from today's $22.71. That is up +97% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Claritev Corporation's 2050 outlook centres on $521.06, within a $234.48 to $1,198.44 range. That is up +154% on the projected 2040 average. That marks a +21.9x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CTEV today (≈ 44.033465 CTEV) could be worth
$22,944.14
+$21,944.14 (+2194%) by 2050 · US Dollar
Based on the average projected CTEV price of $521.06 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CTEVwould be worth at today's price.
$1,000 invested in CTEV on Jul 31, 2025 (≈ 25.081516 CTEV) would be worth
$569.6
-$430.4 (-43.0%) today · 0.57× · US Dollar
Based on a CTEV entry price of $39.87 vs. today's $22.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.61 | $1,050.9 | +5.1% |
| 1 month ago | $32.4 | $700.93 | -29.9% |
| 3 months ago | $24.93 | $910.95 | -8.9% |
| 6 months ago | $27.78 | $817.49 | -18.3% |
| 1 year ago | $39.87 | $569.6 | -43.0% |
| All time (5.0y) ago | $310.4 | $73.16 | -92.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CTEV forecast.
Our base-case forecast reaches $45.00 around 2030.
Implied market cap at $45.00: $767.15M
The multi-year forecast points to a bullish trajectory for Claritev, with the average price rising from $23.40 in 2026 to higher levels over time. By 2030, the average price is projected at $51.21 with an ROI of 118.8, and the sentiment is BULLISH. By 2040, the average price is projected at $210.13 with an ROI of 798, maintaining a BULLISH stance.
By 2050, the average price is projected at $540.05 with an ROI of 2207.9, again with a BULLISH sentiment.
Earlier years show continued growth in the forecast sequence: 2027 avg 29.58; 2028 avg 34.13; 2029 avg 43.24, with ROIs of 26.4, 45.9, and 84.8 respectively, and bullish sentiment. The 2026 forecast is conservative, with an avg of 23.40, a min of 13.47, a max of 39.19, and an ROI of 0. These figures illustrate a long-run upside potential, while underscoring that outcomes are estimates and not guarantees.
Investors should consider the inherent uncertainty in long-horizon forecasts.
Tap a question to reveal the answer.
2030 forecast: min $32.87, avg $51.21, max $86.11; ROI 118.8; sentiment BULLISH.
The forecast shows a bullish sentiment from 2027 onward with rising averages and positive ROIs: 2027 avg 29.58, ROI 26.4; 2028 avg 34.13, ROI 45.9; 2029 avg 43.24, ROI 84.8; 2030 avg 51.21, ROI 118.8; 2040 ROI 798; 2050 ROI 2207.9.
Yes. The forecasted maximum prices reach above $100, with 2032 max $161.07, 2033 max $177.97, and 2034 max $205.12.
Current price $23.40; Market cap $398.92M.
30-day range low $16.98, high $32.25.
Claritev Corporation Community Discussion
0Share your Claritev Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.